Gene-editing technology developer Crispr Therapeutics has secured $38m to increase a round backed by $65m from Bayer and Vertex Pharmaceuticals to $140m.

The workplace performance monitoring technology provider has completed a series B round that will fund sales, marketing, and research and development.

Novartis reinvested in Annexon, which is developing treatments for neurodegenerative diseases, and which has now raised $79m in total.

The round was led by Monsanto's corporate venturing unit, Monsanto Growth Ventures, and follows a $3m series A two years earlier.

Saudi Aramco, Airbus and Schlumberger all took part in a round that boosted the GV-backed industrial collaboration technology company's total funding to about $28m.

Direct selling company Vorwerk's corporate venturing vehicle made its second investment in Juniqe as part of the affordable art platform's series B round.

Sales communication platform Outreach became the fifth company to receive funding from Microsoft Ventures in the space of a month, raising $17.5m in series B capital.

Access Industries' Israel-based subsidiary co-led cyberthreat detection software provider LightCyber's latest round, taking its overall funding to more than $31m.

The automated drone systems developer has added Wilson Sonsini Goodrich and Rosati to its shareholders and signed a partnership with Nvidia.

Axel Springer-backed mobile banking service provider Number26 has closed a series B round and boosted its total funding to approximately $53m.